Peran Plasmafaresis pada Terapi Pasien Sepsis dengan Myasthenia Gravis

Ahmad Imron; Dita Aditianingsih; Yohanes W George

doi:10.14710/jai.v5i3.6311

DOI: https://doi.org/10.14710/jai.v5i3.6311

Peran Plasmafaresis pada Terapi Pasien Sepsis dengan Myasthenia Gravis

Ahmad Imron^{1, 2} , Dita Aditianingsih^{3, 4}, Yohanes W George^{5, 4}

¹Bagian Anestesi dan Terapi Intensif/ Rumah Sakit Mitra Keluarga , Indonesia

²Bekasi, Indonesia

³Bagian Anestesi dan Terapi Intensif, Fakultas Kedokteran,, Indonesia

⁴ Universitas Indonesia, Indonesia

⁵ Bagian Anestesi dan Terapi Intensif, Fakultas Kedokteran, , Indonesia

View all affiliations

Published: 1 Nov 2013.

Citation Format:

Abstract

Pendahuluan : Plasmapheresis berpotensi untuk menghilangkan mediator berbahaya atau beracun dari sirkulasi . Plasmapheresis telah menunjukkan peningkatan keluaran yang bermakna pada penyakit autoimun . Kemanjuran theurapetic dan keamanan plasmapheresis dalam pengobatan pasien di sepsis berat dan syok septik telah dipelajari .

Kasus : Seorang perempuan berusia 18 tahun didiagnosis dengan gagal nafas karena myasthenia gravis dan sepsis berat akibat pneumonia . Dia dirujuk dari rumah sakit lain setelah kegagalan obat antikolinesterase untuk mengobati gejala dari myasthenia gravis. x foto thorax menunjukkan infiltrat di paru-paru kanan paracardial dan basal . Terapi yang diberikan selama di ICU adalah antibiotik , obat-obatan suportif, dan plasmapheresis dilakukan selama 4 kali . Setelah antibiotik yang sesuai diberikan dan plasmapheresis selesai, pasien menunjukkan perbaikan kekuatan otot. Pasien berhasil disapih dari ventilator pada hari ke - 9 , dan kembali ke bangsal di hari - 10 .

Ringkasan : Plasmapheresis memainkan peran penting dalam pengobatan myasthenia gravis dengan sepsis . Plasmapheresis digunakan untuk menghapus berbagai factor pemicu dalam plasma , seperti antibodi , imunoglobulin abnormal dan kompleks imun dalam sirkulasi

Fulltext View|Download

Keywords: myasthenia gravis; plasmapharesis; terapi intensif

Article Metrics:

Article Info

Section: Original Articles

Language : ID

In Vol 5, No 3 (2013): JAI (Jurnal Anestesiologi Indonesia)

Recent articles

Peran Plasmafaresis pada Terapi Pasien Sepsis dengan Myasthenia Gravis Pengaruh Asam Traneksamat pada Profil Koagulasi Pasien yang Mendapatkan Ketorolak Klonidin 1,5 Mcg/Kgbb Intravena Dibandingkan Dengan Fentanil 2 Mcg/ Kgbb Intravena Terhadap Respon Hemodinamik Akibat Tindakan Laringoskopi dan Intubasi Endotrakeal Manajemen Anestesi pada Pasien dengan Kistoma Ovarii Permagna Penatalaksanaan Anestesi pada Koreksi Atresia Esophagus dan Atresia Esofagus More recent articles

Most cited articles

Patofisiologi Penyakit Jantung Koroner Midazolam Intravena Dosis Rendah Tidak Mempengaruhi Nitric Oxide Intraperitoneal Mencit Balb/C Yang Terpapar Lipopolisakarida More cited articles

Yang KS,Kenpe K, Yamaji K Plasma Adsorption in Critical Care, Ther Apher 2002 6(3):184–188
Siami GA,Siami FS. Membrane Plasmapheresis in the United States: a review over the last 20 years. Ther Apher 2000, 5(4):315–320
Gilhus, NE, Autoimmune myasthenia gravis , Expert Rev. Neurother. 9(3), 351–358 (2009)
Turner C. A review of myasthenia gravis: Pathogenesis, clinical features and treatmet., Current Anaesthesia & Critical Care (2007) 18, 15–23
Throuth AJ, Dabi A, Solieman N. Myasthenia Gravis: A Review. Autoimmune Diseases Volume 2012, Article ID 874680
Simon SS, Challu AP, Chacko RK. Trismus as first presenting complaint in a case of myasthenia gravis. Indian J Dent Res 2011;22:729-30
Rice TW, Gordon RB. Theurapetic intervention and target on sepsis, Annu. Rev. Med. 2005. 56:225-48
American Thoracic Society : Guidelines for the management of adults with hospital acquired, venlator-associated and healthcare-assosiated pnemonia. Am J Respir Crit Care Med 2005;171:388-416
Gelfand EW, Intravenous Immune Globulin in Autoimmune and Inflammatory Diseases, N Engl J Med 2012;367:2015-25
Blaha M,Pit’ha J,Lanska M. Extracorporeal Immunoglobulin Elimination for the Treatment of SevereMyasthenia Gravis. Journal of Biomedicine and Biotechnology, Volume 2010, Article ID 419520
Mandawat A. Outcome of plasmapharesis in Myasthenia Gravis: delayed therapy is not favorable. Muscle Nerve, 2011Apr;43(4):578-84

Last update:

No citation recorded.

Last update: 2024-11-27 00:39:29

No citation recorded.

The Authors submitting a manuscript do so on the understanding that if accepted for publication, copyright of the article shall be assigned to JAI (Jurnal Anestesiologi Indonesia) and Department of Anesthesiology and Intensive Therapy, Faculty of Medicine, Diponegoro University as publisher of the journal. Copyright encompasses exclusive rights to reproduce and deliver the article in all form and media, including reprints, photographs, microfilms, and any other similar reproductions, as well as translations.

JAI (Jurnal Anestesiologi Indonesia) and Department of Anesthesiology and Intensive Therapy, Faculty of Medicine, Diponegoro University and the Editors make every effort to ensure that no wrong or misleading data, opinions or statements be published in the journal. In any way, the contents of the articles and advertisements published in JAI (Jurnal Anestesiologi Indonesia) are the sole and exclusive responsibility of their respective authors and advertisers.

The Copyright Transfer Form can be downloaded here:[Copyright Transfer Form JAI]. The copyright form should be signed originally and send to the Editorial Office in the form of original mail, scanned document:

Mochamat (Editor-in-Chief)

Editorial Office of JAI (Jurnal Anestesiologi Indonesia)

Department of Anesthesiology and Intensive Therapy, Faculty of Medicine, Diponegoro University/ Dr. Kariadi General Hospital Medical Center (RSUP Dr. Kariadi)

Jl. Dr. Soetomo No. 16 Semarang, Central Java, Indonesia, 50231

Telp. : (024) 8444346

Email : janestesiologi@gmail.com